AbbVie | ABBV - Les Intérêts Débiteurs Sur La Dette

Prix De L'Action
198.71
Variation Quotidienne
-2.24 -1.11%
Mensuellement
-4.09%
Annuel
6.80%
Q2 Prévisions
194.46




Les Intérêts Débiteurs Sur La Dette Changement Date
AbbVie USD 740M 40M 2025-06
Abbott USD 68M 26M 2026-03
ALKERMES USD 12.28M 7.63M 2025-12
Amgen USD 653M 32M 2025-12
AstraZeneca USD 484M 181M 2025-12
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Coherus Biosciences USD 2.25M 76K 2025-12
Eisai JPY 1.43B 12M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Gilead Sciences USD 255M 1000K 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Infinity Pharmaceuticals USD 45K 0 2023-06
J&J USD 43M 25M 2026-03
Medtronic USD 181M 0 2025-12
Merck USD 412M 85M 2025-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 304M 23M 2025-12
Pacira USD 3.89M 387K 2025-12
Perrigo USD 10.08B 10.04B 2025-09
Pfizer USD 711M 59M 2025-12
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 178M 203M 2026-03
UCB EUR 49M 29M 2025-12
Ultragenyx Pharmaceutical USD 19M 4.85M 2025-12
United Therapeutics USD 3.1M 100K 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12
Zoetis USD 57M 1000K 2025-12